The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Claudin18.2-specific CAR T cells (Satri-cel) versus treatment of physician's choice (TPC) for previously treated advanced gastric or gastroesophageal junction cancer (G/GEJC): Primary results from a randomized, open-label, phase II trial (CT041-ST-01).
 
Changsong Qi
No Relationships to Disclose
 
Chang Liu
No Relationships to Disclose
 
Zhi Peng
No Relationships to Disclose
 
Yanqiao Zhang
No Relationships to Disclose
 
Jia Wei
No Relationships to Disclose
 
Wensheng Qiu
No Relationships to Disclose
 
Xiaotian Zhang
No Relationships to Disclose
 
Hongming Pan
No Relationships to Disclose
 
Zuoxing Niu
No Relationships to Disclose
 
Meng Qiu
No Relationships to Disclose
 
Yanru Qin
No Relationships to Disclose
 
Weijia Fang
No Relationships to Disclose
 
Feng Ye
No Relationships to Disclose
 
Ning Li
No Relationships to Disclose
 
Tianshu Liu
No Relationships to Disclose
 
Yumeng Wang
Employment - CARsgen Therapeutics Co., Ltd.
 
Daijing Yuan
Employment - CARsgen Therapeutics Co., Ltd.
 
Zonghai Li
Employment - CARsgen Therapeutics Co., Ltd.
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)